-+ 0.00%
-+ 0.00%
-+ 0.00%

Ardelyx Completes Enrollment In Phase 3 ACCEL Clinical Trial Of IBSRELA

Benzinga·11/03/2026 13:04:13
Listen to the news

Trial fully enrolled ahead of schedule

Topline data expected in the second half of 2027